NM_001378454.1:c.72_74delGGA

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_001378454.1(ALMS1):​c.72_74delGGA​(p.Glu25del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0385 in 698,502 control chromosomes in the GnomAD database, including 613 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. E24E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.055 ( 348 hom., cov: 0)
Exomes 𝑓: 0.034 ( 265 hom. )

Consequence

ALMS1
NM_001378454.1 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 3.18

Publications

7 publications found
Variant links:
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]
ALMS1 Gene-Disease associations (from GenCC):
  • Alstrom syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001378454.1
BP6
Variant 2-73385903-TGGA-T is Benign according to our data. Variant chr2-73385903-TGGA-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 193378.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALMS1NM_001378454.1 linkc.72_74delGGA p.Glu25del disruptive_inframe_deletion Exon 1 of 23 ENST00000613296.6 NP_001365383.1
ALMS1NM_015120.4 linkc.72_74delGGA p.Glu25del disruptive_inframe_deletion Exon 1 of 23 NP_055935.4 Q8TCU4
LOC105374804XR_007087045.1 linkn.-225_-223delTCC upstream_gene_variant
LOC105374804XR_007087053.1 linkn.-225_-223delTCC upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALMS1ENST00000613296.6 linkc.72_74delGGA p.Glu25del disruptive_inframe_deletion Exon 1 of 23 1 NM_001378454.1 ENSP00000482968.1 Q8TCU4-1

Frequencies

GnomAD3 genomes
AF:
0.0546
AC:
7831
AN:
143476
Hom.:
344
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0949
Gnomad AMI
AF:
0.0170
Gnomad AMR
AF:
0.113
Gnomad ASJ
AF:
0.0316
Gnomad EAS
AF:
0.0424
Gnomad SAS
AF:
0.0136
Gnomad FIN
AF:
0.0458
Gnomad MID
AF:
0.0142
Gnomad NFE
AF:
0.0233
Gnomad OTH
AF:
0.0450
GnomAD2 exomes
AF:
0.0631
AC:
5258
AN:
83366
AF XY:
0.0545
show subpopulations
Gnomad AFR exome
AF:
0.108
Gnomad AMR exome
AF:
0.172
Gnomad ASJ exome
AF:
0.0365
Gnomad EAS exome
AF:
0.0407
Gnomad FIN exome
AF:
0.0392
Gnomad NFE exome
AF:
0.0252
Gnomad OTH exome
AF:
0.0560
GnomAD4 exome
AF:
0.0343
AC:
19023
AN:
554922
Hom.:
265
AF XY:
0.0323
AC XY:
9565
AN XY:
296246
show subpopulations
African (AFR)
AF:
0.0885
AC:
1389
AN:
15688
American (AMR)
AF:
0.155
AC:
4808
AN:
31096
Ashkenazi Jewish (ASJ)
AF:
0.0327
AC:
572
AN:
17516
East Asian (EAS)
AF:
0.0352
AC:
1075
AN:
30534
South Asian (SAS)
AF:
0.0127
AC:
708
AN:
55622
European-Finnish (FIN)
AF:
0.0403
AC:
1458
AN:
36146
Middle Eastern (MID)
AF:
0.0166
AC:
40
AN:
2410
European-Non Finnish (NFE)
AF:
0.0234
AC:
7860
AN:
335948
Other (OTH)
AF:
0.0371
AC:
1113
AN:
29962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
891
1782
2672
3563
4454
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0547
AC:
7850
AN:
143580
Hom.:
348
Cov.:
0
AF XY:
0.0555
AC XY:
3865
AN XY:
69632
show subpopulations
African (AFR)
AF:
0.0949
AC:
3791
AN:
39948
American (AMR)
AF:
0.114
AC:
1669
AN:
14694
Ashkenazi Jewish (ASJ)
AF:
0.0316
AC:
105
AN:
3322
East Asian (EAS)
AF:
0.0423
AC:
194
AN:
4584
South Asian (SAS)
AF:
0.0134
AC:
57
AN:
4262
European-Finnish (FIN)
AF:
0.0458
AC:
430
AN:
9392
Middle Eastern (MID)
AF:
0.0150
AC:
4
AN:
266
European-Non Finnish (NFE)
AF:
0.0233
AC:
1496
AN:
64316
Other (OTH)
AF:
0.0456
AC:
90
AN:
1972
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
327
655
982
1310
1637
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0231
Hom.:
1022

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Mar 18, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 11, 2020
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 05, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 04, 2013
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 12, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 30, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Alstrom syndrome Benign:4
Jul 07, 2023
Molecular Genetics, Royal Melbourne Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Nov 19, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.2
Mutation Taster
=75/25
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55889738; hg19: chr2-73613031; COSMIC: COSV105092295; COSMIC: COSV105092295; API